Auxetic Venous Stent
Chronic venous outflow obstruction / Post-thrombotic Syndrome (PTS)
Key Facts
About Auxetics
Auxetics is a biomechanics-driven medical device startup targeting the significant unmet need in venous disease treatment, specifically post-thrombotic syndrome (PTS). The company's lead product is a novel auxetic venous stent designed to mitigate stent-adjacent stenosis (SAS), a common complication of current stents that reduces venous inflow and worsens outcomes. By applying both radial and longitudinal force, the stent aims to preserve the natural geometry of the vein, potentially improving long-term patency and patient quality of life. The company is in the pre-clinical/development stage, led by a team of physicians and engineers, and is positioned to address a large and growing global market for venous interventions.
View full company profile